EN DE
STOCK COMPARISON

Abbott Laboratories vs TransMedics Group: Fair Value & Quality

Both stocks run through our valuation models. Here is how Abbott Laboratories (ABT) and TransMedics Group (TMDX) compare, as of Sep 5, 2026.

As of Sep 5, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Abbott Laboratories trades at $109 versus a fair value of $74.79 (-31%), while TransMedics Group trades at $86.98 versus $50.86 (-42%).
Abbott Laboratories
ABT · USD · Health Care
-31%
upside to fair value
overvalued
Price$109
Fair Value$74.79
Quality67/100
TransMedics Group
TMDX · USD · Health Care
-42%
upside to fair value
overvalued
Price$86.98
Fair Value$50.86
Quality55/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Abbott LaboratoriesTransMedics Group
Valuation
27.7×P/E (TTM)16.9×
3.89×P/S (TTM)4.02×
3.36×P/B5.40×
15.1×EV/EBITDA20.5×
1.47×PEG—
−31.3%Fair value upside−41.5%
2.2%Dividend yield2.1%
$2.44Dividend per share—
Profitability
13%Operating margin8%
1.19×EBIT margin trend (5Y)—
12%Return on equity45%
6%Return on assets5%
Growth
8%Revenue growth (YoY)21%
0.5%Avg. growth/yr (3Y)86.4%
5.1%Avg. growth/yr (5Y)88.2%
+10.4%Value creation/yr—
Balance & size
23.6×Interest coverage (EBIT/interest)7.9×
0.19×Debt / equity1.06×
$175BMarket cap$3B
healthyGrowth qualityhealthy

Abbott Laboratories leads: 9 to 3 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Abbott Laboratoriesof which business quality 66 · market factors 52 TransMedics Groupof which business quality 59 · market factors 17
ProfitabilityMargins and returns on capital today
50
79
Quality GrowthAre margins and returns improving?
47
83
CashflowEarnings quality: real cash, not paper profit
71
70
Fin. StrengthBalance sheet, leverage, solvency risk
80
72
InvestmentDisciplined investing over empire-building
65
19
Low VolatilityCalm price path (market factor)
83
2
MomentumPrice trend over the last 3–12 months (market factor)
42
26
52W MomentumDistance to the 52-week high (market factor)
34
20
Net IssuanceBuybacks instead of dilution
84
0

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyAbbott LaboratoriesPrice $109TransMedics GroupPrice $86.98
DCF Models-33%below the price$73.01+17%above the price$102
Earnings-Based-73%below the price$29.42+122%above the price$193
Dividend Discount-63%below the price$39.73-72%below the price$24.13
Multiples-35%below the price$70.72-33%below the price$57.96
Asset-Based-82%below the price$20.05-89%below the price$9.17
Growth DCF-38%below the price$67.02+6%close to the price$92.55
Economic Profit-66%below the price$37.49-32%below the price$59.36
Growth Earnings-35%below the price$70.25+194%above the price$256
Minimum-82%below the price$20.05-89%below the price$9.17
Maximum-33%below the price$73.01+194%above the price$256
Median-51%below the price$53.37-13%close to the price$75.96
Geometric mean-57%below the price$46.36-24%below the price$65.85

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

TransMedics Group: 14 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Abbott Laboratories
Bear $51.13Fair Value $74.79Bull $94.43
$109 = current price (white tick)
TransMedics Group
Bear $38.15Fair Value $50.86Bull $114
$86.98 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-31% · above median

TransMedics Group · Health Care

Quality score55 · above median
Fair value upside-42% · below median

Bottom line

As of Sep 5, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Abbott Laboratories trades at $109 versus a fair value of $74.79 (-31%), while TransMedics Group trades at $86.98 versus $50.86 (-42%).

Abbott Laboratories has the higher quality score (67/100).

See the full analysis →
Abbott Laboratories · TransMedics Group

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Abbott Laboratories

Abbott Laboratories vs UnitedHealth GroupEli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth Group

Related to TransMedics Group

Merck & Company vs UnitedHealth GroupAstraZeneca vs UnitedHealth GroupThermo Fisher Scientific vs UnitedHealth GroupAmgen vs UnitedHealth Group
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.